Cer is known to mediate lipotoxicity, contributing to inflammation, impaired insulin signaling and apoptosis, which promotes CVD risk factors, such as hypertension, diabetes, dyslipidemia and kidney disease (Table 1). This evidence concerns the gene INS and metabolic syndrome.